Received: Accepted: Published: Version of record: Issue date: DOI: Comments According to figure 4b, GLP-1MK-801 treated rats lost almost 10% of their weight within 1 day
While researchers did not find a dramatic increase in malformations compared to insulin use, they urged caution due to uncertainty and limited safety data on newer drugs
If you experience severe pain in your stomach area that will not go away, with or without vomiting, while taking a GLP-1 agonist, stop taking your medication and call your healthcare provider right away
Which means the true risk isnt consumer weight loss-its inventory inertia
Nature 628 , 154161 (2024)
The combination is a real dehydration risk, particularly for tirzepatide users where dehydration from GI side effects has been associated with kidney complications